Fact Sheet Number 154
- WHAT IS POST EXPOSURE PROPHYLAXIS?
- WHO SHOULD USE PEP?
- SHOULD PEP BE USED FOR NON-OCCUPATIONAL
EXPOSURE?
- HOW IS PEP TAKEN?
- WHAT ARE THE SIDE EFFECTS?
- THE BOTTOM LINE
- FOR MORE INFORMATION
this Fact Sheet on a single page using: |
|
|
|
More information on Downloading & Printing Fact Sheets |
WHAT IS POST-EXPOSURE PROPHYLAXIS?
Prophylaxis means disease prevention. Post-exposure prophylaxis
(or PEP) means taking antiviral medications as soon as possible
after exposure to HIV, so that the exposure will not result in
HIV infection. These medications are only available with a prescription.
PEP?
Workplace exposure: PEP has been standard procedure
since 1996 for healthcare workers exposed to HIV. Workers start
taking medications within a few hours of exposure. Usually the
exposure is from a “needle stick”, when a health care
worker accidentally gets jabbed with a needle containing HIV-infected
blood. PEP reduced the rate of HIV infection from workplace exposures
by 79%. However, some health care workers who take PEP still get
HIV infection.
Other exposure: In the last few years, community
activists and researchers began asking why PEP shouldn’t be used
after HIV exposures that are not work-related. People can be exposed
to HIV during unsafe sexual activity, when a condom breaks during
sex, or if they share needles for injecting drugs. Infants can
be exposed if they drink breast milk from an infected woman. In
a study of PEP in 400 cases of possible sexual exposure to HIV,
not one person became infected with HIV.
USED FOR NON-OCCUPATIONAL EXPOSURE?
HIV exposure at work is usually a one-time accident. Other HIV
exposures may be due to unsafe behaviors that can occur many times.
Some people think that PEP might encourage this unsafe behavior
if people think that PEP is an easy way to avoid HIV infection.
There are other reasons why PEP might not be a good idea for non-occupational
exposure:
- There is no research to show that PEP works for non-occupational
exposure. We don’t know how soon after exposure to HIV someone
has to start PEP.
- PEP is not a “morning-after pill”. It is a program
of several drugs, several times each day, for at least 30 days.
PEP costs between $600 and $1,000.
- For best results, you have to take every dose of every PEP
medication. Missing doses could mean that you develop HIV infection.
It could also allow the virus to develop resistance to the medications.
If that happens they would no longer work for you.
- The medications have serious side effects. About 40% of health
care workers did not complete PEP because of the side effects.
Despite these concerns, a few cities are starting to offer
PEP for non-occupational exposure. These programs include counseling
to inform and encourage people to avoid exposure to HIV.
PEP should be started as soon as possible after exposure to HIV.
The medications used in PEP depend on the exposure to HIV. The
following situations are considered serious exposure:
- Exposure to a large amount of blood
- Blood came in contact with cuts or open sores on the skin
- Blood was visible on a needle that stuck someone
- Exposure to blood from someone who has a high viral load
(a large amount of virus in the blood).
For serious exposures, the U.S. Public Health Service recommends
using a combination of three approved antiviral drugs for four
weeks. For less serious exposure, the guidelines recommend four
weeks of treatment with two drugs: AZT
and 3TC.
In January 2001, the Centers for Disease Control warned against
using nevirapine for PEP because of the risk of liver damage.
See Fact Sheet 431 for more
information on nevirapine.
EFFECTS?
The most common side effects from PEP medications are nausea and
generally not feeling well. Other possible side effects include
headaches, fatigue, vomiting and diarrhea. For more information,
see fact sheets 420 through 446 on individual antiviral medications.
Post-exposure prophylaxis (PEP) is the use of antiviral drugs
as soon as possible after exposure to HIV, to prevent HIV infection.
PEP can reduce the rate of infection in health care workers exposed
to HIV by 79%.
The benefits of PEP for non-occupational exposure have not
been proven. This use of PEP is controversial because some people
fear it will encourage unsafe behaviors.
PEP is a four-week program of two or three antiviral medications,
several times a day. The medications have serious side effects
that can make it difficult to finish the program. PEP is not 100%
effective; it can not guarantee that exposure to HIV will not
become a case of HIV infection.
CDC guidelines on PEP are on the Internet.
Occupational exposure: http://www.cdc.gov/mmwr/PDF/rr/rr5011.pdf
Non-occupational exposure: http://www.cdc.gov/epo/mmwr/preview/mmwrhtml/00054952.htm
Revised July 26, 2002
to InfoNet Main Page
Index of Fact Sheets
here if you have questions
New Mexico AIDS Education and Training Center
and the New Mexico Department of Health